Dr. Zejnullahu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-476-1000
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2014 - 2017
University of Massachusetts Medical School
Certifications & Licensure
CA State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 786 citationsEML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancerJussi Koivunen, Craig H. Mermel, Kreshnik Zejnullahu, Carly Murphy, Eugene Lifshits
Clinical Cancer Research. 2008-07-01 - 492 citationsActivation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody CetuximabKimio Yonesaka, Kreshnik Zejnullahu, Isamu Okamoto, Taroh Satoh, Federico Cappuzzo
Science Translational Medicine. 2011-09-07 - 117 citationsEvidence that synthetic lethality underlies the mutual exclusivity of oncogenic KRAS and EGFR mutations in lung adenocarcinomaArun M. Unni, William W. Lockwood, Kreshnik Zejnullahu, Shih-Queen Lee-Lin, Harold E. Varmus
Elife. 2015-06-05
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
